ArticleBMC medical imaging2026
Multi-institutional deep learning for GTV segmentation and survival prediction in nasopharyngeal carcinoma.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo develop an automated workflow for gross tumor volume (GTV) segmentation in radiotherapy planning CT images of nasopharyngeal carcinoma (NPC) patients and to evaluate the 5-year Disease-Free Survival (DFS) predictive performance of radiomics, clinical and combined features. METHODS AND MATERIALS: Contrast-enhanced planning CTs of 75 NPC patients were collected. SwinUNETR, UNETR and nnU-Net models were trained with five-fold cross-validation; performance was quantified by Dice similarity coefficient (DSC). Additional 120 scans from SeGrap2023 were incorporated to assess the model performances on diverse cohorts. For DFS prediction, 1059 slice-wise radiomic features were extracted. Feature selection used univariate filtering, correlation thresholding and LASSO, followed by machine-learning modelling with radiomic, clinical and combined inputs.
resultsThe highest 5-fold cross-validation DSC performance was achieved by nnU-Net (DSC = 0.79) when trained and internally validated only on the SeGrap2023 dataset. However, DSC dropped to 0.36 when Acibadem cohort data were utilized for external test set, suggesting a significant effect of the domain shift. When the Acibadem and SeGrap2023 datasets were combined, nnU-Net achieved an average DSC of 0.73 in 5-fold cross-validation and 0.69 on subset of Acibadem internal test cases. In predicting 5-year DFS, a Logistic Regression model using combined radiomic and clinical features provided the highest AUC score (0.79), outperforming clinical-only (AUC = 0.59) and radiomics-only (AUC = 0.63) feature sets.
conclusionsMulti-institutional training mitigates domain shift and boosts segmentation robustness. In addition, integrating radiomics with clinical data enhances DFS prediction in NPC. Advanced deep-learning and machine-learning pipelines can refine radiotherapy planning and prognostication, supporting personalized management and improved outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.